Neocis yesterday said it pulled down $30 million for the Yomi robotic guidance system for dental implant procedures it developed.
Miami-based Neocis, which won 510(k) clearance from the FDA for Yomi in 2017, said it plans to use the proceeds on commercialization and R&D.
Existing investors, including Mithril Capital Management, backed the round, joined by new investor Norwest Venture Partners.
“Having a group of investors and a board of directors so experienced in successfully commercializing robotic surgery will be critical as Neocis charges into the next phase of growth,” co-founder & CEO Alon Mozes, CEO and Co-Founder of Neocis. “This funding will secure our opportunity to expand sales and adoption of Yomi® and continue to innovate in the robotic surgery space.”
added Dr. Robert Mittendorff, Partner at Norwest Venture Partners, will join the Board of Directors. “Norwest is excited to join the Neocis team. We believe there is a huge opportunity for robotics to transform healthcare. Neocis has demonstrated their ability to revolutionize dental surgery,” said Dr. Mittendorff.
